Tapinarof Cream 1%

DRUG2 trials

Sponsors

Teva Pharmaceuticals USA, Pakistan Institute of Medical Sciences

Conditions

Plaque Type PsorisisPsoriasis (PsO)

Phase 3

Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque Psoriasis

CompletedNCT06742957

Teva Pharmaceuticals USAPlaque Type Psorisis

Start: 2024-12-17End: 2025-11-12Updated: 2025-12-17

Phase 4

Efficacy of Topical Tapinarof Versus Betamethasone in the Treatment of Plaque Psoriasis

Not yet recruitingNCT07635043

Pakistan Institute of Medical SciencesPsoriasis (PsO)

Start: 2026-08-01End: 2026-11-30Target: 120Updated: 2026-06-09